Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 20, 2002American Journal of HematologyOpen Access

CD30 and the NPM‐ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

NANorihiro AwayaNovartis (Switzerland)SMShigehisa MoriSaitama Medical University HospitalHTHitoshi TAKEUCHIToho University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Awaya et al. (2002) studied this question.

synapsesocial.com/papers/6a94ea78750ff06d6a767ef0https://doi.org/10.1002/ajh.10059
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Small-Cell-Predominant Variant of Primary Ki-1 (CD30)+ T-Cell Lymphoma1993 · 252 citations
  2. 2Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity1995 · 389 citations
  3. 3Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma1994 · 2,427 citations
  4. 4ALK+ lymphoma: clinico-pathological findings and outcome.1999 · 566 citations
  5. 5Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases1999 · 90 citations